Related Experiment Video
Updated: Aug 2, 2026

10:38
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Molecular vaccines against parasites
P Timms1, A J de Vas, R J Dalgliesh
1QDPI Tick Fever Research Centre, Wacol, Queensland, Australia.
Parasitology Today (Personal Ed.)
|July 1, 1986
Summary
Parasitology research in Australia focuses on developing prophylactic vaccines against various diseases in humans and animals. Key strategies include molecular approaches targeting parasite antigens for effective immune responses.
Area of Science:
- Parasitology
- Vaccinology
- Molecular biology
Background:
- Prophylactic vaccines are a significant output of parasitology research.
- Australian research groups have focused on vaccines for human malaria, livestock parasites (helminths, ticks, babesiosis), and other parasitic infections.
Purpose of the Study:
- To review the progress and strategies in developing parasitic vaccines in Australia.
- To highlight key vaccine programs and methodologies.
Main Methods:
- Analysis of immunology and immunochemistry of model systems.
- Development of monoclonal antibodies and analysis of antibody specificities.
- Screening of expression libraries, peptide synthesis, and optimization of vaccination schedules with adjuvants or novel delivery systems.
Main Results:
- Development of an attenuated Babesia bovis vaccine as the sole available anti-parasitic vaccine in Australia for many years.
- Diverse research efforts targeting a wide range of economically significant and medically important parasites.
Conclusions:
- Molecular vaccine development strategies are largely consistent across different research programs.
- Continued research is crucial for advancing vaccine efficacy and delivery systems against parasitic diseases.
Related Concept Videos
Vaccinations
Overview
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

